Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Clinical trial NCT02062827 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02062827
Sponsor: University of Alabama at Birmingham
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma Multiforme Progressive Glioblastoma Multiforme Anaplastic Astrocytoma or Gliosarcoma

Start date: 2013-11-25
Primary completion: 2022-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.